![Alain Aragues](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alain Aragues
Director/Board Member at European Biopharmaceutical Enterprises
Network origin in Alain Aragues first degree
Entity | Entity type | Industry | |
---|---|---|---|
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium.
5
| Private Company | Biotechnology | 5 |
Leem
4
| Non-Profit Organization | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alain Aragues via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
IMUNON, INC. | Biotechnology | Chief Executive Officer | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
IPSEN | Pharmaceuticals: Major | Chief Operating Officer Public Communications Contact | |
TIGENIX NV | Medical Specialties | Chief Executive Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
CEGEDIM | Packaged Software | Director/Board Member Director/Board Member | |
Afipa SA
![]() Afipa SA Containers/PackagingProcess Industries Part of Covéa SGAM, Afipa SA is a Swiss company that manufactures packaging materials. The company is based in Vevey, Switzerland. | Containers/Packaging | Director/Board Member | |
CFAO | Wholesale Distributors | Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Colegio Universitario de Estudios Financieros | College/University | Masters Business Admin | |
Université Paris 1 Panthéon-Sorbonne | College/University | Masters Business Admin | |
The Hong Kong University of Science & Technology | College/University | Masters Business Admin | |
Pacific Council on International Policy
![]() Pacific Council on International Policy Miscellaneous Commercial ServicesCommercial Services Pacific Council on International Policy operates as a foreign affairs firm. The firm specializes International Affairs, International Relations, Foreign Policy, Foreign Affairs, Public Policy, National Security, International Economics, Government, Professional Networking, Events, Non Profit, International Policy and International Business, Analysis. The company was founded in 1995 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Sanofi-Aventis U.S. LLC
![]() Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Smithkline Beecham Holdings Corp.
![]() Smithkline Beecham Holdings Corp. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beecham Holdings Corp. produces and distributes pharmaceutical products and dental healthcare products. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cellerix SA
![]() Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chief Executive Officer | |
Lundbeck Belgium | Director/Board Member | ||
Laboratoires Mayoly Spindler SAS
![]() Laboratoires Mayoly Spindler SAS Pharmaceuticals: MajorHealth Technology Laboratoires Mayoly Spindler SAS engages in the development of pharmaceutical and dermatology services. The company was founded by Gaston Mayoly in 1929 and is headquartered in Chatou, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Merck Serono SAS
![]() Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lundbeck SAS
![]() Lundbeck SAS Pharmaceuticals: MajorHealth Technology Lundbeck SAS is a pharmaceutical laboratory, which focuses on neurology and psychiatry. The company was founded in 1992 and is headquartered in Paris La Defense, France. | Pharmaceuticals: Major | Chairman | |
Paris Développement | Director/Board Member | ||
Sorbonne Université | College/University | Masters Business Admin | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Sanofi-Aventis France SA
![]() Sanofi-Aventis France SA Medical DistributorsDistribution Services Sanofi-Aventis France engages in wholesale of pharmaceutical products. The company is headquartered in Gentilly, France. | Medical Distributors | Director/Board Member | |
Fondation Paris Diderot | Director/Board Member | ||
Groupement Pour LElaboration Et Al Realisation De Statistique | Chairman | ||
Alliance for Advanced Therapies
![]() Alliance for Advanced Therapies Medical/Nursing ServicesHealth Services The Alliance for Advanced Therapies’ mission is to improve the legislative, business and science climate for advanced therapies innovation in Europe. In order to do so, AAT promotes the interests of its members and the advanced therapies sector in Europe. AAT coordinates input to, and exchanges information with relevant European authorities. The Alliance also increases awareness of the sector among all relevant stakeholders, with a special focus on investors. Furthermore, AAT promotes increased funding for the sector from public and private sources. | Medical/Nursing Services | Chairman | |
OncoDNA SA
![]() OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chief Executive Officer | |
Roche SAS | President | ||
Imaginons La Santé | President | ||
Tigenix SAU
![]() Tigenix SAU Medical SpecialtiesHealth Technology Part of TiGenix NV, Tigenix SAU is a Spanish company that collects all the research and development of health, agri-food and industrial products from its partners. The company is based in Tres Cantos, Spain. The company has been driving biotechnology in Spain since 1999 and have more than 300 associated companies, startups, and entities. The group Zendal, a 100%% Spanish biopharmaceutical group, includes seven companies focused on manufacturing and commercializing high-value biotechnology products. Tigenix SAU is a member of AseBio, and the membership fees vary depending on the type of entity and the company's age, annual turnover, and equity. The company offers discounts and economic advantages to their members. The AseBio Investor Day is an investment forum that aims to connect the Spanish biotechnology industry with investors. | Medical Specialties | Chief Executive Officer | |
Gers SAS SASU | Chairman | ||
ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
Vivet Therapeutics SAS
![]() Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Paris & Co.
![]() Paris & Co. Miscellaneous Commercial ServicesCommercial Services Paris & Co. operates as an economic development and innovation agency. The private company is based in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Chief Executive Officer | |
VIATRIS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sutura Therapeutics Ltd.
![]() Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Sutura Therapeutics Ltd. is a British biopharmaceutical company that is advancing biomolecular medicine through its Peptigo technology platform. The company is based in Macclesfield, UK. Sutura's team is made up of skilled and passionate professionals who bring a unique perspective to the table. The company was founded in 2020, and Edwin J. Wagena has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Engitix Therapeutics Ltd. | Chairman | ||
EUROAPI | Biotechnology | Director/Board Member | |
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chairman | |
Fondation Bordeaux Universite | Investment Trusts/Mutual Funds | Director/Board Member |
Statistics
International
France | 25 |
United States | 11 |
Belgium | 5 |
United Kingdom | 4 |
Spain | 4 |
Sectoral
Health Technology | 22 |
Consumer Services | 8 |
Commercial Services | 6 |
Health Services | 4 |
Distribution Services | 3 |
Operational
Director/Board Member | 48 |
Corporate Officer/Principal | 20 |
Chief Executive Officer | 16 |
Chairman | 10 |
Masters Business Admin | 7 |
Most connected contacts
- Stock Market
- Insiders
- Alain Aragues
- Company connections